Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Margaret A. DiGuardo"'
Autor:
Thomas Z. Thompson, Ashley A. Krull, Dustin J. Strasburg, Jill Adamski, Eapen K. Jacob, Margaret A. DiGuardo
Publikováno v:
Cytotherapy.
Autor:
Jorge A, Trejo-Lopez, Corinne E, Praska, Cinthya, Zepeda Mendoza, Thomas M, Kollmeyer, Aditya, Raghunathan, Caterina, Giannini, Rachael A, Vaubel, Aivi, Nguyen, Mark E, Jentoft, Kliment, Donev, Gang, Zheng, Margaret A, DiGuardo, Benjamin R, Kipp, Robert B, Jenkins, Cristiane M, Ida
Publikováno v:
Journal of Neuropathology & Experimental Neurology. 82:93-95
Autor:
Bruce W. Eckloff, Rory A. Jackson, Mazen A. Atiq, Sarah E. Kerr, Margaret A. DiGuardo, Asha Nair, Kevin C. Halling, Jin Jen, Kandelaria M. Rumilla, Jesse S. Voss, Rondell P. Graham, Jaime I. Davila, Andrew M. Bellizzi, Benjamin R. Kipp, Numrah Fadra, Kay Minn, Dora Lam-Himlin, Shannon M. Knight, Shabnam Zarei, Joseph H. Blommel, Robert B. Jenkins
Publikováno v:
The Journal of Molecular Diagnostics. 23:555-564
Tumor mutation burden (TMB) is an emerging biomarker of immunotherapy response. RNA sequencing in FFPE tissue samples was used for determining TMB in microsatellite-stable (MSS) and microsatellite instability–high (MSI-H) tumors in patients with co
Autor:
Jennifer E. Schieber, Justin E. Juskewitch, Margaret A. DiGuardo, Sheila K. Moldenhauer, Craig D. Tauscher, Eapen K. Jacob
Publikováno v:
Transfusion Medicine and Hemotherapy. 48:244-249
Introduction: Patients with sickle cell disease (SCD) have repeated episodes of red blood cell (RBC) sickling and microvascular occlusion that manifest as pain crises, acute chest syndrome, and chronic hemolysis. These clinical sequelae usually incre
Autor:
Naima J Hashi, Mehrdad Hefazi, William J. Hogan, Mark R. Litzow, Hassan B. Alkhateeb, Mithun V. Shah, Mrinal M. Patnaik, Margaret A DiGuardo, Eapen Jacob, Abhishek Mangaonkar
Publikováno v:
Transplantation and Cellular Therapy. 29:S123
Autor:
Saadiya Nazli, Sarah Wittwer, Margaret A DiGuardo, Christel A Skaer, Justin D. Kreuter, Manish J. Gandhi, Dr. Eapen K Jacob
Publikováno v:
Transplantation and Cellular Therapy. 29:S232
Autor:
Laurie L. Wakefield, Rachel K. Horton, Justin E. Juskewitch, Micah D. Zuccarelli, Margaret A. DiGuardo, Manish J. Gandhi
Publikováno v:
Transfusion. 60:3055-3059
Prozone is a known phenomenon affecting immunoassays causing falsely low or negative results when excess target is present in the test system. For assays used to evaluate immune-mediated platelet (PLT) transfusion refractoriness, prozone-like phenome
Autor:
Sandra C. Bryant, Sheila K. Moldenhauer, Craig D. Tauscher, Margaret A. DiGuardo, Eapen K. Jacob
Publikováno v:
TransfusionREFERENCES. 61(12)
Background Daratumumab (Dara), an anti-CD38 monoclonal antibody for hematologic malignancies, interferes with routine blood bank testing, specifically affecting the antibody screen and identification panels. In 2016, the AABB recommended performing a
Autor:
Manish J. Gandhi, Nisar A. Baig, Laurie L. Wakefield, Justin D. Kreuter, Aleh Bobr, Brian A. Dukek, Deborah K. Falbo, Margaret A. DiGuardo
Publikováno v:
Vox sanguinisReferences. 116(1)
Background Daratumumab (DARA), a human IgG1K monoclonal antibody targeting CD38, is used to treat refractory multiple myeloma patients. CD38 is expressed on many cell types (RBCs, granulocytes, lymphocytes, etc.), and thus, DARA can interfere with se
Autor:
William G. Morice, Jesse R Walsh, John Kalantari, Mohamed E. Salama, Darci R. Block, Eric W. Klee, Justin D. Kreuter, Margaret A. DiGuardo, Amy L Piazza, Saranya Sankaranarayanan, Yanhong Wu, Kathy L Bates, Collin A Osborne, Kia Khezeli, Jagadheshwar Balan, Benjamin R. Kipp, Sara Minnich, John C. O’Horo, Jessica Lesko, Gavin R. Oliver, Garrett Jenkinson
Publikováno v:
Journal of Medical Internet Research
Background COVID-19 is caused by the SARS-CoV-2 virus and has strikingly heterogeneous clinical manifestations, with most individuals contracting mild disease but a substantial minority experiencing fulminant cardiopulmonary symptoms or death. The cl